BOSTON SCIENTIFIC CORPORATION

(BSX)
  Report
Delayed Nyse  -  04:00 2022-07-05 pm EDT
37.76 USD   -0.66%
10:49aEvercore ISI Lowers Boston Scientific's Price Target to $45 From $50, Maintains Outperform Rating
MT
06/29Canaccord Genuity Adjusts Boston Scientific's Price Target to $43 from $51, Keeps Buy Rating
MT
06/29Boston Scientific Announces Conference Call Discussing Second Quarter 2022 Results
PR
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/28/2022 06/29/2022 06/30/2022 07/01/2022 07/05/2022 Date
37.5(c) 37.8(c) 37.27(c) 38.01(c) 37.76 Last
9 890 645 5 749 598 8 127 123 5 870 032 5 790 949 Volume
-0.85% +0.80% -1.40% +1.99% -0.66% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 12 830 M - -
Net income 2022 1 296 M - -
Net Debt 2022 5 713 M - -
P/E ratio 2022 40,3x
Yield 2022 -
Sales 2023 13 781 M - -
Net income 2023 1 967 M - -
Net Debt 2023 3 552 M - -
P/E ratio 2023 27,4x
Yield 2023 -
Capitalization 53 981 M 53 981 M -
EV / Sales 2022 4,65x
EV / Sales 2023 4,17x
Nbr of Employees 41 000
Free-Float 84,2%
More Financials
Company
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.9%): products used in cardiology surgeries (41.9% of net sales), cardiac rhythm management (27.9%), peripheral surgeries (25.1%), and other (5.1%); - endodontic surgery (31.4%): equipment used in endoscopy (57.5% of net... 
More about the company
Ratings of Boston Scientific Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about BOSTON SCIENTIFIC CORPORATION
10:49aEvercore ISI Lowers Boston Scientific's Price Target to $45 From $50, Maintains Outperf..
MT
06/29Canaccord Genuity Adjusts Boston Scientific's Price Target to $43 from $51, Keeps Buy R..
MT
06/29Boston Scientific Announces Conference Call Discussing Second Quarter 2022 Results
PR
06/27INSIDER SELL : Boston Scientific
MT
06/24BTIG Adjusts Boston Scientific's Price Target to $45 From $52, Reiterates Buy Rating
MT
06/15Nucor, Hertz Global rise; Methode, iQIYI fall
AQ
06/15SECTOR UPDATE : Health Care Stocks Gain Pre-Bell Wednesday
MT
06/15SECTOR UPDATE : Health Care
MT
06/15Boston Scientific to Buy 64% of M.I. Tech for About $230 Million
DJ
06/15Boston Scientific to Buy Majority Stake in M.I.Tech
MT
06/15Boston Scientific Announces Agreement to Purchase Majority Stake of M.I.Tech Co., Ltd f..
PR
06/15Boston Scientific Corporation has entered into a definitive agreement to acquire a 63.9..
CI
05/27Boston Scientific's Shares Rise After Needham Upgrade
MT
05/27WALL STREET STOCK EXCHANGE : Wall Street on track to end the week in the green
05/27ANALYST RECOMMENDATIONS : Boston Scientific, Dollar General, Dollar Tree, Macy's, VMWare....
More news
News in other languages on BOSTON SCIENTIFIC CORPORATION
06/15MISE À JOUR SECTORIELLE : Les actions du secteur de la santé gagnent avant la cloche mercr..
06/15MISE À JOUR SECTORIELLE : Soins de santé
05/27Les actions de Boston Scientific augmentent après la mise à niveau de Needham
05/17VENTE D'INITIÉS : Boston Scientific
05/17Onto Innovation déclare que Mark Slicer a été nommé nouveau directeur financier
More news
Analyst Recommendations on BOSTON SCIENTIFIC CORPORATION
More recommendations
Chart BOSTON SCIENTIFIC CORPORATION
Duration : Period :
Boston Scientific Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 37,76 $
Average target price 48,36 $
Spread / Average Target 28,1%
EPS Revisions
Managers and Directors
Michael F. Mahoney Chairman, President & Chief Executive Officer
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Jodi Eddy Senior VP, Chief Information & Digital Officer
Edward F. Mackey Executive Vice President-Global Operations
Sector and Competitors